Protecting a blockbuster diabetes treatment for AstraZeneca
AstraZeneca AB
Major victories across IP venues for Volkswagen, Audi, Bentley, and Lamborghini
Audi AG; Audi of America, LLC; Automobili Lamborghini America, LLC; Automobili Lamborghini S.p.A.; Bentley Motors Limited; Bentley Motors, Inc; Volkswagen AG; Volkswagen Group of America, Inc.
No confusion in trademark victory on summary judgment for the American Retirement Association
American Retirement Association
Finnegan helps Intellia Therapeutics acquire Rewrite Therapeutics, Inc. for $45 million
Intellia Therapeutics, Inc.
Finnegan secures favorable ITC ruling related to innovative electric SUVs for BMW
BMW of North America, LLC and Bayerische Motoren Werke AG
Finnegan fights for Sony’s “exceedingly famous” mark
Sony Group Corporation
Experience
Rare PTAB rehearing request granted for Finnegan client Incyte Rare PTAB rehearing request granted for Finnegan client Incyte
IPR2017-01256, PTAB, Judges Fitzpatrick, Hulse, Yang, Smith, Franklin
19-2011, Fed. Cir., Judges Hughs, Linn, Stark
Experience
Merck Sharp & Dohme LLC v. Hetero USA Inc., Lupin Limited et al. Merck Sharp & Dohme LLC v. Hetero USA Inc., Lupin Limited et al.
2:23-cv-00094, 2:23-cv-02364, D.N.J., Judges Cecchi, Padin, Wettre
Experience
Risen (Suzhou) Pharma Tech Co., Ltd. v. Alzheon, Inc. Risen (Suzhou) Pharma Tech Co., Ltd. v. Alzheon, Inc.
IPR2022-01200, PGR2022-00051, PTAB, Judges Newman, Snedden, Wisz
22-2232, Fed. Cir.
Experience
Teva Pharmaceuticals International GmbH v. Eli Lilly and Company Teva Pharmaceuticals International GmbH v. Eli Lilly and Company
IPR2022-00738, -00739, -00796, PTAB, Judges Cotta, Wisz, Worth
1:21-cv-10954, D. Mass., Judge Burroughs
Experience
Nanosys, Inc. v. The Board of Trustees of the University of Arkansas et al. Nanosys, Inc. v. The Board of Trustees of the University of Arkansas et al.
IPR2020-00503, PTAB, Judges Abraham, Guest, Heaney
Experience
SFC Co., Ltd. v. LG Chem, Ltd. SFC Co., Ltd. v. LG Chem, Ltd.
IPR2020-00178, -00182, PTAB, Judges Kalan, Kaiser, Abraham
Experience
Finnegan persuades PTAB that all claims in high-pressure tubular polyethylene manufacturing process and apparatus patent are unpatentable Finnegan persuades PTAB that all claims in high-pressure tubular polyethylene manufacturing process and apparatus patent are unpatentable
IPR2017-01534, PTAB, Judges Abraham, Roesel, Tornquist
Experience
Finnegan successfully defends Incyte against institution of PGR proceeding Finnegan successfully defends Incyte against institution of PGR proceeding
PGR2017-00034, PTAB, Judges Paulraj, Sawert, Snedden
Experience
Eli Lilly and Company v. Actavis Labs. UT Inc. Eli Lilly and Company v. Actavis Labs. UT Inc.
1:16-cv-01119, E.D. Va., Judges Nachmanoff, Trenga
Experience
Eli Lilly and Company v. Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center Eli Lilly and Company v. Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center
IPR2014-00693, -00752, PTAB, Judges Green, Prats, Snedden
16-1547, Fed. Cir., Judges Bryson, Moore, Newman
Experience
Federal Circuit, district court, and arbitration victories protect Cumberland Pharmaceuticals’ flagship product, Acetadote® Federal Circuit, district court, and arbitration victories protect Cumberland Pharmaceuticals’ flagship product, Acetadote®
16-1155, -1259, Fed. Cir., Judges Moore, Reyna, Taranto
1:12-cv-03846, N.D. Ill., Judge Pallmeyer
Experience
Actelion Pharmaceuticals v. ICOS Corp. Actelion Pharmaceuticals v. ICOS Corp.
IPR2015-00561, -00562, PTAB, Judges Mitchell, Snedden, Yang
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.